Compile Data Set for Download or QSAR
Report error Found 80 Enz. Inhib. hit(s) with all data for entry = 2719
TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376962BDBM376962(US9920060, 50 | US10329300, Example 50 | US1169691...)
Affinity DataIC50: 2.90nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376933BDBM376933(US9920060, 27 | US10329300, Example 27 | US1169691...)
Affinity DataIC50: 3.90nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376912BDBM376912(US9920060, 6 | US10329300, Example 6 | US11696917,...)
Affinity DataIC50: 4nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376924BDBM376924(US9920060, 18 | US10329300, Example 18 | US1169691...)
Affinity DataIC50: 4.40nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376920BDBM376920(US9920060, 14 | US10329300, Example 14 | US1169691...)
Affinity DataIC50: 4.60nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376988BDBM376988(US9920060, 76 | US10329300, Example 76 | US1169691...)
Affinity DataIC50: 5nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376948BDBM376948(US9920060, 36 | US10329300, Example 36 | US1169691...)
Affinity DataIC50: 5.40nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376923BDBM376923(US9920060, 17 | US10329300, Example 17 | US1169691...)
Affinity DataIC50: 5.90nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376945BDBM376945((R)-4-(1-(1-acryloylpiperidin-3-yl)-4-amino-1H-pyr...)
Affinity DataIC50: 6nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376941BDBM376941(US9920060, 29 | US10329300, Example 29 | US1169691...)
Affinity DataIC50: 6.5nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376932BDBM376932(US9920060, 26 | US10329300, Example 26 | US1169691...)
Affinity DataIC50: 7nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376909BDBM376909(US9920060, 3 | US10329300, Example 3)
Affinity DataIC50: 7.10nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376913BDBM376913(US9920060, 7 | US10329300, Example 7 | US11696917,...)
Affinity DataIC50: 7.10nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376918BDBM376918(US9920060, 12 | US10329300, Example 12 | US1169691...)
Affinity DataIC50: 7.5nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376917BDBM376917(US9920060, 11 | US10329300, Example 11 | US1169691...)
Affinity DataIC50: 7.5nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376980BDBM376980((R)-4-(1-(1-acryloylpyrimidin-3-yl)-4-amino-1H-pyr...)
Affinity DataIC50: 7.70nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376908BDBM376908(US9920060, 2 | US10329300, Example 2)
Affinity DataIC50: 8.30nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376960BDBM376960(US9920060, 48 | US10329300, Example 48 | US1169691...)
Affinity DataIC50: 8.5nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376921BDBM376921(US9920060, 15 | US10329300, Example 15 | US1169691...)
Affinity DataIC50: 8.60nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376942BDBM376942(US9920060, 30 | US10329300, Example 30 | US1169691...)
Affinity DataIC50: 8.70nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376981BDBM376981(US9920060, 69 | US11696917, Example 69)
Affinity DataIC50: 9.20nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376914BDBM376914(US9920060, 8 | US10329300, Example 8 | US11696917,...)
Affinity DataIC50: 9.20nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376944BDBM376944(US9920060, 32 | US10329300, Example 32 | US1169691...)
Affinity DataIC50: 9.30nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376907BDBM376907(US9920060, 1 | US10329300, Example 1)
Affinity DataIC50: 10nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376922BDBM376922(US9920060, 16 | US10329300, Example 16 | US1169691...)
Affinity DataIC50: 10nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376925BDBM376925(US9920060, 19 | US10329300, Example 19 | US1169691...)
Affinity DataIC50: 10nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376915BDBM376915(US9920060, 9 | US10329300, Example 9 | US11696917,...)
Affinity DataIC50: 10nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376950BDBM376950(US9920060, 38 | US10329300, Example 38 | US1169691...)
Affinity DataIC50: 10nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376982BDBM376982(US9920060, 70 | US11696917, Example 70)
Affinity DataIC50: 10nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376949BDBM376949(US9920060, 37 | US10329300, Example 37)
Affinity DataIC50: 11nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376911BDBM376911(US9920060, 5 | US10329300, Example 5)
Affinity DataIC50: 11nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376946BDBM376946(US9920060, 34 | US10329300, Example 34 | US1169691...)
Affinity DataIC50: 11nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376984BDBM376984(US9920060, 72 | US11696917, Example 72)
Affinity DataIC50: 11nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376983BDBM376983(US9920060, 71 | US10329300, Example 71 | US1169691...)
Affinity DataIC50: 11nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376970BDBM376970((R)-4-(1-(1-acryloylpyrrolidin-3-yl)-4-amino-1H-py...)
Affinity DataIC50: 11nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376910BDBM376910(US9920060, 4 | US10329300, Example 4)
Affinity DataIC50: 12nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376943BDBM376943(US9920060, 31 | US10329300, Example 31 | US1169691...)
Affinity DataIC50: 13nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376964BDBM376964(US9920060, 52 | US10329300, Example 52 | US1169691...)
Affinity DataIC50: 13nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376926BDBM376926(US9920060, 20 | US10329300, Example 20 | US1169691...)
Affinity DataIC50: 13nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376973BDBM376973(US9920060, 62 | (R)-1-(1-acryloylpyrrolidin-3-yl)-...)
Affinity DataIC50: 13nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376989BDBM376989(US9920060, 77 | US10329300, Example 77 | US1169691...)
Affinity DataIC50: 13nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376919BDBM376919(US9920060, 13 | US10329300, Example 13 | US1169691...)
Affinity DataIC50: 13nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376916BDBM376916(US9920060, 10 | US10329300, Example 10 | US1169691...)
Affinity DataIC50: 13nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376990BDBM376990(1-((3R,5S)-1-acryloyl-5-methylpyrrolidin-3-yl)-4-a...)
Affinity DataIC50: 14nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376965BDBM376965(US9920060, 53 | US10329300, Example 53 | US1169691...)
Affinity DataIC50: 14nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376955BDBM376955(US9920060, 43 | US10329300, Example 43 | US1169691...)
Affinity DataIC50: 14nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376947BDBM376947(US9920060, 35 | US10329300, Example 35 | US1169691...)
Affinity DataIC50: 16nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376987BDBM376987(US9920060, 75 | US10329300, Example 75 | US1169691...)
Affinity DataIC50: 16nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376991BDBM376991(US9920060, 79)
Affinity DataIC50: 17nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

TargetReceptor tyrosine-protein kinase erbB-2(Human)
Taiho Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 376963BDBM376963(US9920060, 51 | US10329300, Example 51 | US1169691...)
Affinity DataIC50: 17nMAssay Description:For the inhibitory activity measurement of each compound, the compound of the present invention or staurosporine was first serially diluted with dime...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/4/2020
Entry Details
US Patent

Displayed 1 to 50 (of 80 total ) | Next | Last >>
Jump to: